AskGene Pharma

AskGene Pharma, based in Camarillo, the United States, is a biotechnology company. AskGene Pharma develops cytokine prodrug therapeutics using its SmartKine platform technology, targeting oncology and autoimmune disease indications. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials, testing ASKG915 and Fruquintinib in gastric & gastro-oesophageal junction cancer. The largest, NCT05867420 (A Study of ASKG915 in Patients With Selected Advanced Solid Tumours), plans to enrol 594 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.